GISSI HF

Related by string. * : GISSI / HFD . h f . HFs . Hfd . HFS . hf . Hf . HfS . hfs : frequencies LF HF . HF Gerry Lenfest . OPTIMIZE HF . HF VHF . CCP hf . EMPHASIS HF trial . EMPHASIS HF . ASCEND HF . HF RFID tags . HF inlays . HF V2 . MedWatch HF 2 . Landsbanki Islands hf . ADMIRE HF . #.#MHz HF RFID . HF #.#MHz . #.#MHz HF . Glitnir banki hf . HF Verwoerd . HF bands . High Frequency HF . Glitnir Banki hf . HF L . HFS + * *

Related by context. Frequent words. (Click for all words.) 60 prospective observational 59 ALLHAT 58 multicentre 58 Acute Myocardial Infarction 58 randomized clinical 58 placebo controlled clinical 58 Acute Coronary Syndrome 58 substudy 58 phase IIa 57 Cardiovascular Risk 57 Ischemic 57 Pharmacokinetic 57 randomized controlled clinical 57 Multicenter 57 prospective randomized controlled 57 randomized Phase III 56 subgroup analyzes 56 prospective cohort 56 multicenter 56 Myocardial Infarction 56 omecamtiv mecarbil 56 pharmacodynamic 56 TRITON TIMI 55 coronary revascularization 55 acute coronary syndromes 55 multicenter clinical 55 ADHF 55 lipid lowering therapy 55 multicenter randomized 55 SPIRIT III 54 SWOG 54 pharmacodynamic effects 54 retrospective cohort study 54 cardiac dysfunction 54 perindopril 54 Phase III randomized 54 Rosuvastatin 54 T2DM 54 placebo controlled randomized 54 EORTC 54 valsartan 54 acute ischemic stroke 54 tolvaptan 53 acute myocardial infarction AMI 53 Heart Failure Patients 53 morbidity mortality 53 phase IIb 53 randomized controlled 53 cardiovascular mortality 53 tumor lysis syndrome 53 myocardial infarction MI 53 acute coronary syndrome 53 left ventricular dysfunction 53 SYNTAX 53 PRECiSE 53 myocardial infarction stroke 53 blind randomized controlled 53 multicenter study 53 sunitinib 53 microalbuminuria 52 observational studies 52 Congestive Heart Failure 52 uncontrolled hypertension 52 Pivotal Phase III 52 echocardiographic 52 risk stratification 52 prespecified 52 lacosamide 52 Secondary endpoints 52 double blinded placebo 52 Phase 1a 52 stable angina 52 myocardial infarction 52 Phase Ia 52 ischemic stroke 52 rosuvastatin 52 nesiritide 52 secondary efficacy endpoints 52 Secondary endpoints include 52 acute myocardial infarction 52 statistically significant p = 52 cardiovascular 52 NT proBNP 51 dronedarone 51 observational study 51 cardiovascular morbidity 51 confirmatory Phase III 51 glatiramer acetate 51 pharmacoeconomic 51 tanespimycin 51 hypertensive patients 51 placebo controlled studies 51 pertuzumab 51 renal transplantation 51 acute coronary 51 fasting glucose levels 51 fondaparinux 51 blind randomized 51 serum calcium 51 NSABP 51 Pioglitazone

Back to home page